Chemical and physical enhancers and ultrasound for transdermal d

Surgery – Means for introducing or removing material from body for... – With means for cutting – scarifying – or vibrating tissue

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

601 2, A61B 1700

Patent

active

059479213

ABSTRACT:
Transdermal transport of molecules during sonophoresis (delivery or extraction) can be further enhanced by providing chemical enhancers which increase the solubility of the compound to be transported and/or lipid bilayer solubility, and/or additional driving forces for transport, such as mechanical or osmotic pressure, magnetic fields, electroporation or iontophoresis. In a preferred embodiment the ultrasound is low frequency ultrasound which induces cavitation of the lipid layers of the stratum corneum (SC). This method provides higher drug transdermal fluxes, allows rapid control of transdermal fluxes, and allows drug delivery or analyte extraction at lower ultrasound intensities and other forces or concentrations than that required if each means of enhancing transport is used individually.

REFERENCES:
patent: 3551554 (1970-12-01), Herschler
patent: 3711602 (1973-01-01), Herschler
patent: 3711606 (1973-01-01), Herschler
patent: 4002221 (1977-01-01), Buchalter
patent: 4127125 (1978-11-01), Takemoto et al.
patent: 4144646 (1979-03-01), Takemoto et al.
patent: 4176664 (1979-12-01), Kalish
patent: 4249531 (1981-02-01), Hiller et al.
patent: 4280494 (1981-07-01), Cosgrove, Jr. et al.
patent: 4309989 (1982-01-01), Fahim
patent: 4372296 (1983-02-01), Fahim
patent: 4537776 (1985-08-01), Cooper
patent: 4557943 (1985-12-01), Rosler et al.
patent: 4563184 (1986-01-01), Korol
patent: 4646725 (1987-03-01), Moasset
patent: 4698058 (1987-10-01), Greenfeld et al.
patent: 4767402 (1988-08-01), Kost et al.
patent: 4780212 (1988-10-01), Kost et al.
patent: 4820720 (1989-04-01), Sanders et al.
patent: 4821740 (1989-04-01), Tachibana et al.
patent: 4834978 (1989-05-01), Nuwayser
patent: 4855298 (1989-08-01), Yamada et al.
patent: 4860058 (1989-08-01), Kobayashi et al.
patent: 4863970 (1989-09-01), Patel et al.
patent: 4953565 (1990-09-01), Tachibana et al.
patent: 5006342 (1991-04-01), Cleary et al.
patent: 5007438 (1991-04-01), Tachibana et al.
patent: 5016615 (1991-05-01), Driller
patent: 5019034 (1991-05-01), Weaver et al.
patent: 5076273 (1991-12-01), Schoendorfer et al.
patent: 5115805 (1992-05-01), Bommannan et al.
patent: 5139023 (1992-08-01), Stanley et al.
patent: 5140985 (1992-08-01), Schroder et al.
patent: 5171215 (1992-12-01), Flanagan
patent: 5197946 (1993-03-01), Tachibana
patent: 5231975 (1993-08-01), Bommannan et al.
patent: 5267985 (1993-12-01), Shimada et al.
patent: 5315998 (1994-05-01), Tachibana et al.
patent: 5323769 (1994-06-01), Bommannan et al.
patent: 5386837 (1995-02-01), Sterzer
patent: 5401237 (1995-03-01), Tachibana et al.
patent: 5405614 (1995-04-01), D'Angelo et al.
patent: 5415629 (1995-05-01), Henley
patent: 5421816 (1995-06-01), Lipkovker
patent: 5445611 (1995-08-01), Eppstein et al.
patent: 5458140 (1995-10-01), Eppstein et al.
patent: 5582586 (1996-12-01), Tachibana et al.
patent: 5658247 (1997-08-01), Henley
Egorov, E.A. et al., "Use of the Variants of the Pharmacophysical Influence in Ophthalmology", 102 Ophthalmology Journal #2 (1992).
Eppstein, D.A. et al., "Applications of Liposome Formulations for Antimicrobial/Antiviral Therapy" Liposomes as Drug Carriers 311, 315 (G. Gregoriadis ed. 1988).
Eppstein, D.A., "Medical Utility of Interferons: Approaches to Increasing Therapeutic Efficacy" 7 Pharmacy International 195-198 (1986).
Eppstein, D.A. et al., "Alternative Delivery Systems for Peptides and Proteins as Drugs" 5 CRC Reviews in Therapeutic Drug Carrier Systems 99, 125 (1988).
Loshilov, V.I. et al., "Research of the Technological Process of Ultrasound Treatment of Infected Wounds" (1976).
Ulashik, V.S. et al., Ultrasound Therapy (Minsk, Belarus 1983).
Apfel, R.F., "Possiblity of Microcavitation from Diagnostic Ultrasound," IEEE Trans. Ultrason. Ferroelectrics Freq. Control UFFC-33:139-142 (1986).
Aungst, et al., "Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines," Pharm. Res. 7:712-718 (1990).
Barry, "Mode of Action of Penetration Enhancers in Human Skin," J. Controlled Rel. 6:85-97 (1987).
Bommer, et al., "Subcutaneous Erythropoeitin," Lancet 406 (1988).
Burnette, R. R., "Iontophoresis," Transdermal Drug Delivery Developmental Issues and Research Initiatives (Hadgraft and Guv. Editors, Marcel Dekker, 247-291, 1989).
Cleary, Gary W., "Transdermal Controlled Release Systems," Medical Applications of Controlled Release (Langer and Wise, Editors, CRC Press 203-251, 1984).
Clegg and Vaz, "Translational diffusion of proteins and lipids in artificial lipid bilayer membranes. A comparison of experiment with theory," Progress in Protein-Lipid Interactions Watts, ed. (Elsvier, NY 1985) Chapter 5:173-229.
Davis, J.,et al., "Characterization of Recombinant Human Erythropoietin Produced in Chinese Hamster Ovary Cells," Biochemistry 26:2633-2638 (1987).
Ebert, et al., "Transbuccal Absorption of Diclofenac Sodium in a Dog Model," Controlled Release Technology Pharmaceutial Application (Lee, et al. Editors, American Chemical Society)310-321 (1987).
Eggerth, et al., "Evaluation of Hamster Cheek Pouch as a Model for Buccal Absorption," Proceed. Intern. Symp. Rel. Bioact. Mater.,(Controlled Release Society, Inc.) 14:180-181 (1987).
D'Emanuele, et al., "An Investigation of the Effects of Ultrasound on Degradable Polyanhydride Matrices," Macromolecules 25:511-515 (1992).
Elias, "The Microscopic Structure of the Epidermis and Its Derivatives," Percutaneous Absorption: Mechanisms- Methodology-Drag Delivery (Bronaugh, R. L., Maibach, H., Editors, Marcel Dekker, New York,) 1-12 (1989).
Flynn, G. L., "Mechanism of Percutaneous Absorption from Physiochemical Evidence," Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery (Bronaugh, R.L., Maibach, H., Editors, Marcel Dekker, New York) 27-51 (1989).
Friedman, R. M., `Interferons: A Primer`, (Academic Press, New York, 1981).
Gaertner, W., "Frequency Dependence of Ultrasonice Cavitation," J. Acoust. Soc. Am. 26:977-980 (1954).
Ghanem et al., "The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach," Int. J. Pharm. 78:137-156 (1992).
Grups and Frohmuller, "Cyclic Interferon Gamma Treatment of Patients with Metastatic Renal Carcinoma," J. Med. 64(3):218-220 (1989).
Hansch and Leo, "Substitutent Constants for Correlation Analysis in Chemistry and Biology" (1979).
Junginger, et al., "Visualization of Drug Transport Across Human Skin and the Influence of Penetration Enhancers," "Drug Permeation Enhancement" (Hsieh, D.S., Editors, Marcel Dekker, Inc. New York) 59-89 (1994).
Kasting, et al., "Prodrugs for Dermal Delivery: Solubility, Molecular Size, and Functional Group Effects," "Prodrugs: Topical and Ocular Delivery" Sloan, ed. (Marcel Dekker, NY 1992) 117-161.
Kost and Langer, "Ultrasound-Mediated Transdermal Drug Delivery," Topical Drug Bioavailability Bioequivalence and Penetration (Maibach, H. I., Shah, V. P., Editors, Plenum Press, New York) 91-104 (1993).
Kost, et al., "Ultrasound Effect on Transdermal Drug Delivery," (Ben Gurion University Dept. of Chem. Engineering, Beer Sheva Israel) (MIT, Dept. of Appliced Biological Sciences, Cambridge, MA) CRS Aug. 1986.
Krall, L.P., `World Book of Diabetes in Practice` (Editors, Elsvier, 1988).
Lee, V. H. L., et al., "Protease Inhibition as an Additional Mechanism for the Nasal Absorption Enhancement Effect of Sodim Taurodihydrofusidate," Proceed. Intern. Symp. Control. Rel. Bioact. Mater 14:55-56 (1987).
Lee, V. H. L., et al., "Nasal Peptide and Protein Absorption Promotors: Aminopeptidase Inhibition as a Predictor of Absorption Enhancement Potency of Bile Salts," Proceed. Intern. Symp. Control. Rel. Bioact. Mater 14:53-54 (1987).
Levy, et al., "Effect of Ultrasound on Transdermal Drug Delivery to Rats and Guinea Pigs," J. Clin. Invest. 83:2074-2078 (1989).
Liu, et al., "Contransport of Estradiol and Ethanol Through Human Skin In Vitro: Understanding the Permeant/Enhancer Flux Relationship," Pharmaceutical Research 8:938-944 (1991).
Liu, et al., "Experimental Approa

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Chemical and physical enhancers and ultrasound for transdermal d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemical and physical enhancers and ultrasound for transdermal d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical and physical enhancers and ultrasound for transdermal d will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1798940

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.